Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

EOlife®

K-Number: K221841 · 2023-03-18

ApplicantArcheon
Decision Date2023-03-18
Product CodeBTM
Advisory CommitteeAN
DecisionSubstantially Equivalent

Device Summary

EOlife® is a medical device manufactured by Archeon. It received FDA 510(k) clearance on 2023-03-18 under approval number K221841. The device is classified under product code BTM. It was reviewed by the AN advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the EOlife®?

EOlife® is a medical device that received FDA 510(k) clearance on 2023-03-18. It is manufactured by Archeon. The 510(k) number is K221841.

When was EOlife® approved by the FDA?

EOlife® received FDA 510(k) clearance on 2023-03-18, under approval number K221841.

What company makes EOlife®?

EOlife® is manufactured by Archeon.

What is the FDA product code for EOlife®?

The FDA product code for EOlife® is BTM.

Related Devices (Code: BTM)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.